title: The pharmaceutical industry and health reform: lessons from Europe.
abstract: Many countries in Europe, which have significant pharmaceutical industries, recently have embarked on reforms in the organization of their health care systems and methods of regulating the pharmaceutical market. This paper describes the different systems in major European countries and the changes taking place. Although it is too early to make final judgment on the impact of these changes, it is possible to predict some of the more likely outcomes. The organizational models and regulatory approaches in Europe offer a useful store of experience for those assessing the potential impact of reform proposals in the United States.
authors.forename: J
authors.initials: J
authors.lastname: Hutton
authors.forename: M
authors.initials: M
authors.lastname: Borowitz
authors.forename: I
authors.initials: I
authors.lastname: Oleksy
authors.forename: B R
authors.initials: BR
authors.lastname: Luce
mesh_terms: D003363:Cost Control; D004345:Drug Industry / Q000331:legislation & jurisprudence* / Q000458:organization & administration; D005060:Europe; D018166:Health Care Reform / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D007880:Legislation, Drug / Q000191:economics*; D013678:Technology, Pharmaceutical / Q000191:economics / Q000331:legislation & jurisprudence